LOCACORTEN VIOFORM

This brand name is authorized in Canada, Finland, Netherlands, New Zealand

Active ingredients

The drug LOCACORTEN VIOFORM contains a combination of these active pharmaceutical ingredients (APIs):

1 Flumetasone UNII 0DV09X6F21 - FLUMETHASONE PIVALATE

Read about Flumetasone

2 Clioquinol UNII 7BHQ856EJ5 - CLIOQUINOL

Read about Clioquinol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07CB05	Flumetasone and antibiotics	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics → D07CB Corticosteroids, moderately potent, combinations with antibiotics
Discover more medicines within D07CB05
S02CA02	Flumetasone and antiinfectives	S Sensory organs → S02 Otologicals → S02C Corticosteroids and antiinfectives in combination → S02CA Corticosteroids and antiinfectives in combination
Discover more medicines within S02CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00074454, 00074462
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 175398
Country: NL	Z-Index G-Standaard	Identifier(s): 15082296
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 1716, 6041
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14456